BioPharma Credit PLC
BPCP.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £1,028,125 | £1,059,827 | £1,056,120 | £1,177,420 |
| - Cash | £4,305 | £5,620 | £37,144 | £135,053 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £1,023,820 | £1,054,207 | £1,018,976 | £1,042,367 |
| Revenue | £56,200 | £45,312 | £79,145 | £57,221 |
| % Growth | 24% | -42.7% | 38.3% | – |
| Gross Profit | £83,779 | £45,312 | £79,145 | £57,221 |
| % Margin | 149.1% | 100% | 100% | 100% |
| EBITDA | £53,000 | £0 | £0 | -£7 |
| % Margin | 94.3% | 0% | 0% | -0% |
| Net Income | £53,018 | £50,340 | £71,838 | £37,523 |
| % Margin | 94.3% | 111.1% | 90.8% | 65.6% |
| EPS Diluted | 0.046 | 0.042 | 0.058 | 0.029 |
| % Growth | 9.8% | -27.2% | 100.3% | – |
| Operating Cash Flow | £24,589 | £64,269 | £47,643 | £92,776 |
| Capital Expenditures | £0 | £0 | £0 | £0 |
| Free Cash Flow | £24,589 | £64,269 | £47,643 | £92,776 |